GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

leronlimab   Click here for help

GtoPdb Ligand ID: 10752

Synonyms: PRO 140 | PRO-140 | PRO140 | Vyrologix®
Immunopharmacology Ligand
Compound class: Antibody
Comment: Leronlimab (PRO140) is a humanized anti-CCR5 (C-C motif chemokine receptor 5) monoclonal antibody [5-6]. It was originally developed by CytoDyn as a novel strategy to manage CCR5-tropic HIV infection [4].

SARS-CoV-2 and COVID-19: Leronlimab has been administered to a number of patients with severe COVID-19, to determine its potential to reduce cytokine storm caused by this disease.
Classification Click here for help
Compound class Antibody
International Nonproprietary Names Click here for help
INN number INN
10751 leronlimab
Synonyms Click here for help
PRO 140 | PRO-140 | PRO140 | Vyrologix®
Database Links Click here for help
Specialist databases
GPCRdb Ligand leronlimab
IMGT/mAb-DB 807
Other databases
GtoPdb PubChem SID 405560193
Search PubMed clinical trials leronlimab
Search PubMed titles leronlimab
Search PubMed titles/abstracts leronlimab